SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 311.44 |
| Enterprise Value ($M) | 499.90 |
| Book Value ($M) | 401.90 |
| Book Value / Share | 8.05 |
| Price / Book | 0.77 |
| NCAV ($M) | 39.98 |
| NCAV / Share | 0.80 |
| Price / NCAV | 7.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.94 |
| Current Ratio | 5.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 341.57 |
| Assets | 703.49 |
| Liabilities | 301.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 228.38 |
| Operating Income | -67.06 |
| Net Income | -114.76 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.32 |
| Cash from Investing | 176.81 |
| Cash from Financing | -161.53 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Alger Associates Inc | 5.20 | -4.88 | |
| 13G/A | Brown Capital Management Llc | 9.02 | -13.45 | |
| 13G/A | Cadian Capital Management, Lp | 9.97 | 14.10 | |
| 13G/A | Vanguard Group Inc | 5.74 | 0.00 | |
| 13G/A | Integrated Core Strategies (us) Llc | 7.50 | 32.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 22,249 | 250,106 | 8.90 | |
| 57,485 | 372,570 | 15.43 | |
| 107,640 | 1,025,953 | 10.49 | |
| 160,820 | 1,415,235 | 11.36 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CVKD – Cadrenal Therapeutics, Inc. | CYCC – Cyclacel Pharmaceuticals, Inc. |
| CYCN – Cyclerion Therapeutics, Inc. | CYTH – Cyclo Therapeutics, Inc. |
| DARE – Daré Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io